首页|期刊导航|中华医学杂志（英文版）|Progress of anti-vascular endothelial growth factor therapy for ocular neovascular disease: benefits and challenges

Progress of anti-vascular endothelial growth factor therapy for ocular neovascular disease: benefits and challenges

Xu Jianjiang Li Yimin Hong Jiaxu

中华医学杂志（英文版）2014，Vol.127Issue(8)：1550-1557,8.

中华医学杂志（英文版）2014，Vol.127Issue(8)：1550-1557,8.DOI:10.3760/cma.j.issn.0366-6999.20140017

Progress of anti-vascular endothelial growth factor therapy for ocular neovascular disease: benefits and challenges

Xu Jianjiang ¹Li Yimin ¹Hong Jiaxu¹

作者信息

1. Department of Ophthalmology, Eye, Ear, Nose, and Throat Hospital,School of Shanghai Medicine, Fudan University, Shanghai 200031,China
折叠

摘要

关键词

vascular endothelial growth factor/ anti-vascular endothelial growth factor therapy/ranibizumab/ bevacizumab/ aflibercept/ pegaptanib/ neovascularization/ angiogenesis/ safety

Key words

vascular endothelial growth factor/ anti-vascular endothelial growth factor therapy/ranibizumab/ bevacizumab/ aflibercept/ pegaptanib/ neovascularization/ angiogenesis/ safety

引用本文复制引用

Xu Jianjiang,Li Yimin,Hong Jiaxu..Progress of anti-vascular endothelial growth factor therapy for ocular neovascular disease: benefits and challenges[J].中华医学杂志（英文版）,2014,127(8):1550-1557,8.

基金项目

This work was supported by grants from the Key Clinic Medicine Research Program,the Ministry of Health,China (No.201302015),the National Science and Technology Research Program,the Ministry of Science and Technology,China (No.2012BAI08B01),the National Natural Science Foundation of China (Nos.81170817,81200658),and the Scientific Research Program,Science and Technology Commission of Shanghai Municipality,Shanghai (Nos.13441900900,13430720400,134119a8800,13430710500). （No.201302015）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量2

下载量0

段落导航